Avaleht › Äge bifentüübiline leukeemia › Ohio
Äge bifentüübiline leukeemia kliinilised uuringud osariigis Ohio
8 uuringut haiguse Äge bifentüübiline leukeemia jaoks otsivad osalejaid osariigis Ohio.
Linnad osariigis Ohio
- Columbus5 uuringut
- Cincinnati5 uuringut
- Akron4 uuringut
- Cleveland4 uuringut
- Toledo3 uuringut
- Dayton3 uuringut
Ametlik uuringutekst (inglise keeles)
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- ja veel 2
VärbamineFaas 2
365 Days · Kõik sood · Uuendatud 25. sept 2026 · NCT06317662A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Ohio State University, Columbus
VärbamineFaas 1/2
30 Days · Kõik sood · Uuendatud 16. sept 2026 · NCT04065399Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- ja veel 4
VärbamineFaas 3
365 Days – 25 Years · Kõik sood · Uuendatud 25. aug 2026 · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- ja veel 3
VärbamineFaas 1/2
Kuni 22 aastane · Kõik sood · Uuendatud 25. aug 2026 · NCT04726241Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- The Ohio State University Wexner Medical Center, Columbus
VärbamineFaas 1/2
Vanused 13–90 · Kõik sood · Uuendatud 6. aug 2026 · NCT06533579Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Cincinnati Children's Hospital Medical Center, Cincinnati
VärbamineFaas 1
Vanused 1–30 · Kõik sood · Uuendatud 3. aug 2026 · NCT06177067The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- Gabrail Cancer Center Research,, Canton
VärbamineFaas 1/2
Vanused 12–95 · Kõik sood · Uuendatud 15. apr 2026 · NCT04329728Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies, Cleveland
- Nationwide Children's Hospital, Columbus
VärbamineFaas 1
Vanused 1–21 · Kõik sood · Uuendatud 6. dets 2024 · NCT05476770Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.